Origen de la red de primer grado Matthias van Woensel.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
DROIA NV
DROIA NV Investment ManagersFinance DROIA NV (DROIA) is an Independent Venture Capital firm founded in 2011 by Bart van Hooland. The firm is headquartered in Meise with additional office in Luxembourg.
7
| Private Company | Investment Managers | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Matthias van Woensel a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
TIGENIX NV | Medical Specialties | Corporate Officer/Principal | |
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
GIMV NV | Investment Managers | Director/Board Member | |
LUXEMPART S.A. | Financial Conglomerates | Director of Finance/CFO | |
FOYER SA | Multi-Line Insurance | Director/Board Member | |
FLORIDIENNE S.A. | Food: Specialty/Candy | Director of Finance/CFO | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Language & Computing NV
Language & Computing NV Information Technology ServicesTechnology Services Language & Computing NV (L&C) provides information management technology solutions for the health care and pharmaceutical markets. The firm offers solutions for semantic indexing of free text documents, information retrieval and extraction, terminology management, and automated clinical coding. The company was founded in 1998 and is headquartered in Sint-Denijs-Westrem, Belgium. | Information Technology Services | Director/Board Member | |
Ghent University | College/University | Undergraduate Degree | |
Katholieke Universiteit Leuven | College/University | Undergraduate Degree Doctorate Degree | |
Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
Waterland Private Equity NV | Investment Managers | Private Equity Investor | |
IWT IST
IWT IST Miscellaneous Commercial ServicesCommercial Services IWT IST distributes subsidies for projects submitted by small and large businesses, universities, colleges and other Flemish innovative players, either individually or collectively. The foundation was founded in 1991 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Sage Engineering Corp. | Corporate Officer/Principal | ||
Methexis Genomics NV | Corporate Officer/Principal | ||
TiGenix, Inc. | President | ||
De Warande vzw | Director/Board Member | ||
Voka Vlaams Economisch Verbond VZW | Director/Board Member | ||
Ovizio Imaging Systems SA
Ovizio Imaging Systems SA Electronic ComponentsElectronic Technology Ovizio Imaging Systems SA develops and markets imaging systems and sensors. Its microscopes include iLine F, iLine M, iLine S and QMod. The company was founded by Catherine Yourassowsky, Frank Dubois, Philip Mathuis and Serge Jooris in December 2009 and is headquartered in Brussels, Belgium. | Electronic Components | Director/Board Member | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PX Biosolutions Pty Ltd. | Director/Board Member | ||
Pont NV | Director/Board Member | ||
Tux NV | Director/Board Member | ||
Primix Bio Ventures BV | Chief Executive Officer | ||
Tusk Therapeutics NV
Tusk Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Part of Tusk Therapeutics SA, Tusk Therapeutics NV operates as a research organization. The company is based in Vlaams Brabant, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer | |
CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Founder | |
Tusk Therapeutics SA
Tusk Therapeutics SA Pharmaceuticals: MajorHealth Technology Tusk Therapeutics SA develops and manufactures therapeutic products. The private company is based in Luxembourg, Luxembourg. and has subsidiaries in Belgium. Luc Dochez has been the CEO of the Luxembourger company since 2015. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Premis BV | Chief Executive Officer | ||
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
OCTIMET Oncology NV
OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Biotechnology | Director/Board Member | |
Highlight Therapeutics SL
Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Convert Pharmaceuticals SA
Convert Pharmaceuticals SA Miscellaneous Commercial ServicesCommercial Services Convert Pharmaceuticals SA provides preclinical stage drug development services. Its product hypoxia activated prodrug (HAP) is a therapeutic obstacle as it promotes the development of resistance to conventional anti-cancer treatments. The company was founded by Philippe Lambin, Nicolas Geuens, and Paul Tulcinsky on February 24, 2017 and is headquartered in Liege, Belgium. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Frontier Medicines Corp.
Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Black Belt Therapeutics Ltd.
Black Belt Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Black Belt Therapeutics Ltd. is a British biotechnology company. | Miscellaneous Commercial Services | Director/Board Member | |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Founder | |
Montis Biosciences BV
Montis Biosciences BV BiotechnologyHealth Technology Montis Biosciences BV engages in the development of immune-oncology therapeutics targetting the intersection between vascular dysfunction and immune suppression to treat solid tumors. It offers target screening and assay platform to discover novel targets modulating interactions between tumor endothelial cells and perivascular macrophages. The company was founded by Peter Carmeliet and Massimiliano Mazzone and is headquartered in Meise, Belgium. | Biotechnology | Chairman | |
Muna Therapeutics ApS
Muna Therapeutics ApS Medical/Nursing ServicesHealth Services Muna Therapeutics ApS is a Danish private biopharmaceutical company that discovers and develops therapies to slow or stop neurodegenerative diseases such as Alzheimer's, frontotemporal dementia, and Parkinson's. Muna Therapeutics is based in Copenhagen, DK and was founded in 2020 by Simon Glerup and Bart de Strooper. The company focuses on identifying new medicines to preserve cognition and other brain functions and enhance resilience to these diseases. Rita Balice-Gordon has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
DF II LP NV
DF II LP NV Financial ConglomeratesFinance DF II LP NV is a private company based in Meise, Belgium. The Belgian company was founded in 2018. | Financial Conglomerates | Director/Board Member | |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Mahzi Therapeutics is a private biotechnology company that focuses on genetic therapies for rare genetic neurodevelopmental disorders. The company was founded by Yael Weiss and is based in San Mateo, CA. The company unites patient and family groups, academic researchers, diagnostic companies, other industry members, and its internal team of experts to develop therapies for patients with these serious diseases. Mahzi's team is experienced in all aspects of biopharmaceutical research, development, and manufacturing and is driven to make a difference in the lives of patients with rare genetic diseases. Yael Weiss has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Cascador Health BV
Cascador Health BV Packaged SoftwareTechnology Services Cascador Health BV is a Belgian company that aims to unlock the true value of patient data for better healthcare and better health for individual patients. The company is based in Tielrode, Belgium. The company wants to bridge the gap between data providers and research/industry and become the reference for projects. It was founded in 2021 and the CEO is Philip Taillieu. | Packaged Software | Director/Board Member | |
Summation Bio, Inc. | Director/Board Member | ||
Scala Plastics NV
Scala Plastics NV Wholesale DistributorsDistribution Services Part of Scala International, Scala Plastics NV is a Belgian company that wholesales building materials. The company is based in Wetteren, Belgium. The company was founded in 1964. John Martens has been the CEO of the company since 2018. | Wholesale Distributors | Chief Executive Officer |
Estadísticas
Internacional
Bélgica | 25 |
Estados Unidos | 11 |
Países Bajos | 7 |
Luxemburgo | 4 |
Francia | 3 |
Sectorial
Health Technology | 19 |
Commercial Services | 6 |
Finance | 6 |
Consumer Services | 5 |
Technology Services | 3 |
Operativa
Director/Board Member | 58 |
Private Equity Investor | 7 |
Chief Executive Officer | 7 |
Corporate Officer/Principal | 5 |
Independent Dir/Board Member | 4 |
Las relaciones más conectadas
Insiders | |
---|---|
Bart van Hooland | 38 |
Luc Dochez | 26 |
Janwillem Naesens | 14 |
Lionel de Hemptinne | 4 |
Sandra Schoors | 2 |
Joke Vereecken | 1 |
Luc Verelst | 1 |
- Bolsa de valores
- Insiders
- Matthias van Woensel
- Conexiones Empresas